ReproCELL Incorporated
Provider of stem cell technology and services for research and regenerative medicine.
4978 | T
Overview
Corporate Details
- ISIN(s):
- JP3974770004
- LEI:
- Country:
- Japan
- Address:
- 横浜市港北区新横浜３−８−１１
- Website:
- https://www.reprocell.com/
Description
ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-10 07:03 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2023-08-10 08:03 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2023-08-10 08:02 |
四半期報告書－第22期第1四半期(2023/04/01－2023/06/30)
|
Japanese | ZIP • 182.6 KB | ||
| 2023-06-27 06:19 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2023-06-27 06:18 |
内部統制報告書－第21期(2022/04/01－2023/03/31)
|
Japanese | ZIP • 22.2 KB | ||
| 2023-06-27 06:17 |
有価証券報告書－第21期(2022/04/01－2023/03/31)
|
Japanese | ZIP • 1.1 MB | ||
| 2023-02-10 07:02 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2023-02-10 07:02 |
四半期報告書－第21期第3四半期(2022/10/01－2022/12/31)
|
Japanese | ZIP • 183.0 KB | ||
| 2022-11-09 07:36 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2022-11-09 07:35 |
四半期報告書－第21期第2四半期(令和4年7月1日－令和4年9月30日)
|
Japanese | ZIP • 217.9 KB | ||
| 2022-08-10 08:21 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2022-08-10 08:05 |
四半期報告書－第21期第1四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | ZIP • 186.8 KB | ||
| 2022-06-29 08:04 |
内部統制報告書－第20期(令和3年4月1日－令和4年3月31日)
|
Japanese | ZIP • 22.1 KB | ||
| 2022-06-29 08:03 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2022-06-29 08:02 |
有価証券報告書－第20期(令和3年4月1日－令和4年3月31日)
|
Japanese | ZIP • 1.1 MB |
Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ReproCELL Incorporated
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
